Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bast

Showing results (31-40 of 560) with videos related to

Pageof 56
Sort By:
Cancer Biology & Therapy|June 8, 2011
Src family kinases and paclitaxel sensitivityXiao-Feng Le, Robert C Bast
Methods in Molecular Medicine|February 23, 2011
Alterations in oncogenes, tumor suppressor genes, and growth factors associated with epithelial ovarian cancersR C Bast, G B Mills
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2010
Personalizing therapy for ovarian cancer: BRCAness and beyondRobert C Bast, Gordon B Mills
Important Advances in Oncology|January 1, 1987
The emerging role of monoclonal antibodies in the clinical management of epithelial ovarian carcinomaR C Bast, R C Knapp
Cancer Discovery|May 16, 2012
Dissecting "PI3Kness": the complexity of personalized therapy for ovarian cancerRobert C Bast, Gordon B Mills
The New England Journal of Medicine|December 14, 2004
Individualized care for patients with cancer - a work in progressRobert C Bast, Gabriel N Hortobagyi
Gynecologic Oncology|May 24, 2011
More than a biomarker: CA125 may contribute to ovarian cancer pathogenesisRobert C Bast, David R Spriggs
Cancer Research|August 15, 1993
National Cancer Institute Conference on Investigational Strategies for Detection and Intervention in Early Ovarian CancerH H Gallion, R C Bast
Seminars in Oncology|September 1, 1984
Immunologic approaches to the management of ovarian carcinomaR C Bast, R C Knapp
Clinical Chemistry|July 17, 1998
CA 125 in ovarian cancer: advances and controversyH A Fritsche, R C Bast
Pageof 56

Showing results (31-40 of 560) with videos related to

Sort By:
Pageof 56
Cancer Biology & Therapy|June 8, 2011
Src family kinases and paclitaxel sensitivityXiao-Feng Le, Robert C Bast
Methods in Molecular Medicine|February 23, 2011
Alterations in oncogenes, tumor suppressor genes, and growth factors associated with epithelial ovarian cancersR C Bast, G B Mills
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2010
Personalizing therapy for ovarian cancer: BRCAness and beyondRobert C Bast, Gordon B Mills
Important Advances in Oncology|January 1, 1987
The emerging role of monoclonal antibodies in the clinical management of epithelial ovarian carcinomaR C Bast, R C Knapp
Cancer Discovery|May 16, 2012
Dissecting "PI3Kness": the complexity of personalized therapy for ovarian cancerRobert C Bast, Gordon B Mills
The New England Journal of Medicine|December 14, 2004
Individualized care for patients with cancer - a work in progressRobert C Bast, Gabriel N Hortobagyi
Gynecologic Oncology|May 24, 2011
More than a biomarker: CA125 may contribute to ovarian cancer pathogenesisRobert C Bast, David R Spriggs
Cancer Research|August 15, 1993
National Cancer Institute Conference on Investigational Strategies for Detection and Intervention in Early Ovarian CancerH H Gallion, R C Bast
Seminars in Oncology|September 1, 1984
Immunologic approaches to the management of ovarian carcinomaR C Bast, R C Knapp
Clinical Chemistry|July 17, 1998
CA 125 in ovarian cancer: advances and controversyH A Fritsche, R C Bast
Pageof 56